Table 2 Intra- and postoperative clinical outcomes

Intraoperative sufentanil consumption (μg)

118 ± 32

76 ± 10

< 0.01

Postoperative sufentanil consumption (μg)

108 ± 30

62 ± 15

< 0.01

Parecoxib consumption (mg)

60 ± 20

120 ± 40

< 0.01

Time to extubation (h)

9.7 ± 3.5

2.7 ± 1.8

< 0.01

Time to drain removal (h)

33 ± 8

30 ± 9

0.41

Length of stay in the ICU (h)

27 ± 11

17 ± 5

< 0.05

Incidence of PONV (%)

5(10.2)

7(14.3)

0.54

Time to first feces (h)

42 ± 16

39 ± 11

0.43

Length of hospital stay (h)

208 ± 23

175 ± 15

< 0.05